
Cefpac S 1000mg/500mg Injection
Marketer
Elivia Life Sciences Pvt Ltd
Salt Composition
Ceftriaxone (1000mg) + Sulbactam (500mg)
Overview Cefpac S 1000mg/500mg Injection
Cefpac S 1000mg/500mg Injection, a dual-action antibiotic, combats various bacterial infections by inhibiting microbial proliferation. Administration must be solely under a physician's guidance; strict adherence to the prescribed dosage schedule is crucial, completing the entire course regardless of symptom improvement. Premature cessation may compromise its efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia; worsening symptoms necessitate immediate medical attention. Allergic reactions (e.g., rash, pruritus, edema, dyspnea) demand prompt medical help. Inform your doctor of all current medications, including those for pre-existing conditions, before commencing treatment. Pregnant or lactating individuals require prior medical consultation. Alcohol consumption should be avoided due to potential increased drowsiness. While typically non-impairing, driving is discouraged if drowsiness or dizziness occur. Adequate rest, balanced nutrition, and sufficient hydration are essential for optimal recovery. Your doctor might order lab tests to monitor the medication's impact.
Primary Ingredients of Cefpac S 1000mg/500mg Injection
No text was provided to rewrite.
Uses of Cefpac S 1000mg/500mg Injection
Infections caused by bacteria
Major Benefits of Cefpac S 1000mg/500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Cefpac S 1000mg/500mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Cefpac S 1000mg/500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is not permitted.
How Cefpac S 1000mg/500mg Injection works:
Ceftriaxone and Sulbactam, combined as Cefpac S 1000mg/500mg Injection, offer a dual-action antibacterial approach. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering their growth and survival. Sulbactam, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, thereby optimizing Ceftriaxone's efficacy.
SAFETY ADVICE
AlcoholSAFE
Ingestion of alcohol alongside Cefpac S 1000mg/500mg Injection poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
Cefpac S 1000mg/500mg Injection is typically deemed safe for use in pregnancy. Preclinical trials in animals revealed minimal or absent harm to offspring; nevertheless, clinical data in humans are scarce.
Breast feedingCAUTION
Administering Cefpac S 1000mg/500mg Injection to breastfeeding mothers requires careful consideration. Discontinue breastfeeding throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administration of Cefpac S 1000mg/500mg Injection can cause drowsiness, blurred vision, and dizziness. Driving should be avoided if these side effects are experienced.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Cefpac S 1000mg/500mg Injection to individuals with renal impairment. Seek medical advice from your physician.
LiverCAUTION
Administering Cefpac S 1000mg/500mg Injection requires careful consideration in individuals with advanced hepatic impairment. Dosage modification of Cefpac S 1000mg/500mg Injection might be necessary. Physician consultation is advised. Altering the Cefpac S 1000mg/500mg Injection dosage is not suggested for patients exhibiting mild to moderate liver dysfunction.
What if you forget to take Cefpac S 1000mg/500mg Injection :
Omitting a scheduled dose of Cefpac S 1000mg/500mg Injection necessitates contacting your physician.
Facts to Know About Cefpac S 1000mg/500mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Anti-infective agents |
